Clinical implications of regorafenib-induced hypothyroidism in metastatic colorectal cancer refractory to standard therapies: A prospective evaluation

被引：0
|
作者：
Kim, J. H. [1 ]
Kim, J. E. [1 ]
Kim, S. Y. [1 ]
Kim, K-P. [1 ]
Hong, Y. S. [1 ]
Kim, T. W. [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
598P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Evaluation of Factors Predicting the Effectiveness of Regorafenib in the Treatment of Metastatic Colorectal Cancer
    Ebinc, Senar
    Oruc, Zeynep
    Urakci, Zuhat
    Kalkan, Ziya
    Kaplan, Muhammet Ali
    Kucukoner, Mehmet
    Isikdogan, Abdurrahman
    EURASIAN JOURNAL OF MEDICINE, 2022, 54 (03): : 229 - 234
  • [42] Regorafenib dose optimization study (ReDOS): A phase II randomized study of lower starting dose regorafenib compared to standard dose regorafenib in patients with refractory metastatic colorectal cancer (mCRC)
    Bekaii-Saab, Tanios S.
    Ou, Fang-Shu
    Ciombor, Kristen Keon
    Farhat, Mohamed I.
    Kirshner, Jeffrey J.
    Knost, James A.
    Anderson, Daniel M.
    Soori, Gamini S.
    Boland, Patrick Mckay
    Wender, Donald B.
    Desnoyers, Rodwige J.
    Sargent, Daniel J.
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Regorafenib dose escalation therapy for patients with refractory metastatic colorectal cancer (RECC Study)
    Nakamura, Masato
    Yamada, Takeshi
    Ishiyama, Shun
    Enomoto, Masanobu
    Yokomizo, Hajime
    Kosugi, Chihiro
    Sonoda, Hiromichi
    Ishimaru, Kei
    Ishibashi, Keiichiro
    Kuramochi, Hidekazu
    Nozawa, Keijiro
    Ohta, Ryo
    Takahashi, Makoto
    Yoshida, Hiroshi
    Hashiguchi, Yojiro
    Hirata, Keiji
    Katsumata, Kenji
    Ishida, Hideyuki
    Koda, Keiji
    Sakamoto, Kazuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [44] Efficacy and safety of regorafenib compared to TAS-102 for refractory metastatic colorectal cancer
    Abrahao, Ana Beatriz Kinupe
    Ko, Yoo-Joung
    Chan, Kelvin K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Regorafenib in refractory metastatic colorectal cancer: A multi-center retrospective study.
    Xu, Donghao
    Liu, Yu
    Tang, Wentao
    Xu, Lingsha
    Liu, Tianyu
    Li, Jisheng
    Zhao, Jiemin
    Ye, Le-Chi
    Xu, Jianmin
    Chang, Wenju
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15580 - E15580
  • [46] Regorafenib or Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer? A Perspective on the Basis of Pharmacological Costs
    Giuliani, Jacopo
    Bonetti, Andrea
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : E381 - E383
  • [47] Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management
    Khan, Gazala
    Moss, Rebecca A.
    Braiteh, Fadi
    Saltzman, Marc
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 93 - 103
  • [48] Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study
    Ducreux, Michel
    Petersen, Lone Norgard
    Oehler, Leopold
    Bergamo, Francesca
    Metges, Jean-Philippe
    de Groot, Jan Willem
    Wang, Jaw-Yuan
    Garcia Paredes, Beatriz
    Dochy, Emmanuelle
    Fiala-Buskies, Sabine
    Cervantes, Andres
    Manuel O'Connor, Juan
    Falcone, Alfredo
    EUROPEAN JOURNAL OF CANCER, 2019, 123 : 146 - 154
  • [49] Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"
    Coutzac, Clelia
    Trouilloud, Isabelle
    Pascal, Artru
    Henriques, Julie
    Masson, Therese
    Doat, Solene
    Bouche, Olivier
    Coriat, Romain
    Saint, Angelique
    Moulin, Valerie
    Vernerey, Dewi
    Gallois, Claire
    De La Fouchardiere, Christelle
    Tougeron, David
    Taieb, Julien
    CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 132 - 140
  • [50] Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: A case report (vol 96, e8285, 2017)
    Sonoda, Koh-Hei
    Tsuchihashi, K.
    Shimokawa, H.
    Takayoshi, K.
    MEDICINE, 2017, 96 (44)
12345